A detailed history of Hurley Capital, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Hurley Capital, LLC holds 447 shares of ABT stock, worth $58,123. This represents 0.03% of its overall portfolio holdings.

Number of Shares
447
Previous 436 2.52%
Holding current value
$58,123
Previous $59.3 Million 1.07%
% of portfolio
0.03%
Previous 0.04%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 10, 2025

BUY
$120.51 - $136.62 $1,325 - $1,502
11 Added 2.52%
447 $59.9 Million
Q2 2025

Aug 13, 2025

BUY
$123.95 - $138.08 $247 - $276
2 Added 0.46%
436 $59.3 Million
Q1 2025

May 07, 2025

SELL
$111.1 - $140.22 $11,554 - $14,582
-104 Reduced 19.33%
434 $57.6 Million
Q4 2024

Feb 12, 2025

BUY
$111.93 - $119.39 $60,218 - $64,231
538 New
538 $62.4 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $228B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Hurley Capital, LLC Portfolio

Follow Hurley Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hurley Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hurley Capital, LLC with notifications on news.